425: Focus Impact BH3 Acquisition Company Faces Nasdaq Delisting Amid Business Combination Pursuit

Focus Impact BH3 Acquisition Company (BHAC) received a delisting notice from Nasdaq due to not completing a business combination within the required timeframe, but intends to continue pursuing its merger with XCF Global Capital, Inc.

Summary

• Focus Impact BH3 Acquisition Company (BHAC) received a delisting notice from Nasdaq on October 7, 2024, because it did not complete a business combination within 36 months of its IPO.
• Trading of BHAC's securities will be suspended on Nasdaq effective October 14, 2024.
• Following the suspension, BHAC's Units, shares of Class A common stock, and redeemable warrants will be eligible to trade on the OTC Pink Marketplace under the symbols BHACU, BHAC, and BHACW, respectively.
• BHAC intends to continue pursuing its proposed business combination with XCF Global Capital, Inc.
• The company is also seeking to list the combined entity on Nasdaq or the New York Stock Exchange.
• BHAC and XCF have prepared, and Focus Impact BH3 Newco, Inc. has filed a registration statement on Form S-4 with the SEC, including a prospectus and proxy statement.
• The company urges investors to read the proxy statement/prospectus for important information about BHAC, XCF, and the business combination.
• The company is not making any offer to purchase or sell securities.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice, although the company is trying to remain positive by continuing to pursue the business combination.

Positives

• BHAC intends to continue pursuing its proposed business combination with XCF Global Capital, Inc.
• The company is also seeking to list the combined entity on Nasdaq or the New York Stock Exchange.
• BHAC's securities will be eligible to trade on the OTC Pink Marketplace after the Nasdaq suspension.

Negatives

• BHAC received a delisting notice from Nasdaq due to not completing a business combination within the required timeframe.
• Trading of BHAC's securities will be suspended on Nasdaq effective October 14, 2024.

Risks

• The business combination with XCF may not be completed.
• The combined company may not be listed on Nasdaq or the New York Stock Exchange.
• The level of redemptions by BHAC's public shareholders could impact the cash proceeds available for the business combination.

Future Outlook

BHAC intends to continue pursuing its proposed business combination with XCF Global Capital, Inc. and list the combined company on Nasdaq or the New York Stock Exchange.

Management Comments

• Carl Stanton, Chief Executive Officer, signed the report on behalf of the company.

Industry Context

Many SPACs (Special Purpose Acquisition Companies) have faced challenges in completing business combinations within the required timeframes, leading to delistings and liquidations.

Comparison to Industry Standards

• The 36-month deadline for SPACs to complete a business combination is a common industry standard enforced by exchanges like Nasdaq and NYSE.
• Failure to meet this deadline often results in delisting, similar to what BHAC is experiencing.
• Other SPACs facing similar situations include companies that announced mergers that were later terminated, or those that failed to find suitable targets within the allotted time.

Stakeholder Impact

• Shareholders may experience a decrease in liquidity due to the delisting from Nasdaq.
• The company's reputation may be negatively impacted by the delisting.
• Employees may experience uncertainty regarding the future of the company.

Next Steps

• BHAC will transition trading to the OTC Pink Marketplace.
• BHAC will continue to pursue the business combination with XCF Global Capital, Inc.
• BHAC will seek to list the combined company on Nasdaq or the New York Stock Exchange.
• BHAC will mail the definitive proxy statement/prospectus to its stockholders.

Key Dates